Skip to content

Human dental pulp stem cells (hDPSCs) as treatment for periodontal disease

Effect of human dental pulp stem cells (hDPSCs) on periodontal disease in adults in ageing process and its relation to markers of oxidative stress and inflammation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12831118
Enrollment
40
Registered
2016-07-10
Start date
2016-06-04
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A deep infrabony defect = 4 mm deep caused by periodontal disease Oral Health

Interventions

All patients will be enrolled in a strict nonsurgical periodontal program that included systemic antibiotic therapy, careful instructions on proper oral hygiene measures and subgingival scaling and ro

Sponsors

National Autonomous University of Mexico [UNAM] (Mexico)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients 45 to 64 years old 2. Have atraumatic occlusion but vertical bone defect maximum two walls affected and loss of adhesión 3. = 4 mm deep, controlled chronic degenerative disease 4. Good nutritional status 5. Manually skilled and ability to follow instructions 6. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Smoking 2. People who have taken antioxidant supplements or anti-inflammatories in the last 6 months 3. Family history of osteoporosis 4. Family history of cancer

Design outcomes

Primary

MeasureTime frame
1. Probing depth, gingival recession, and attachment loss via clinical assessments at post-surgery follow-up (3, 6 and 12 months after Phase 1) 2. Evolution of periodontal disease and bone regeneration via Cone-Beam Computed Tomography, radiography and intraoral photographs at post-surgery follow-up (3, 6 and 12 months after Phase 1)

Secondary

MeasureTime frame
1. Concentration of oxidative stress and chronic inflammatory markers by TBARS assay, Total Antioxidant Status, superoxide dismutase activity and quantification of cytokines at post-surgery follow-up (3, 6 and 12 months after Phase 1) 2. Regeneration of bone tissue, via changes in bone density via Cone-Beam Computed Tomography at 3, 6 and 12 months after Phase 1 3. Mobility of teeth, tested clinically by a specialist at 3, 6 and 12 months after Phase 1

Countries

Mexico

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026